关注均匀性，而非剂量：钇-90 经动脉放射性栓塞剂量递增研究之愚行 - Suppr | 超能文献

Focus on Uniformity, Not Dose: The Folly of Yttrium-90 Transarterial Radioembolization Dose-Escalation Studies.

作者信息

Nuffer Zachary

机构信息

Division of Interventional Radiology, Union Hospital, 1606 N 7th St, Terre Haute, IN 47804.

出版信息

J Vasc Interv Radiol. 2024 Jun;35(6):918-919. doi: 10.1016/j.jvir.2023.12.575. Epub 2024 Mar 5.

DOI:10.1016/j.jvir.2023.12.575

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Focus on Uniformity, Not Dose: The Folly of Yttrium-90 Transarterial Radioembolization Dose-Escalation Studies.

J Vasc Interv Radiol. 2024 Jun;35(6):918-919. doi: 10.1016/j.jvir.2023.12.575. Epub 2024 Mar 5.

2

Coil-Assisted Temporary Vascular Occlusion to Protect Tumor-Free Territory during Transarterial Radioembolization.

J Vasc Interv Radiol. 2024 Jun;35(6):929-931. doi: 10.1016/j.jvir.2024.02.013.

3

Acute Biliary Obstruction after Transarterial Radioembolization with Yttrium-90.

J Vasc Interv Radiol. 2019 Dec;30(12):2043-2045. doi: 10.1016/j.jvir.2019.08.024. Epub 2019 Oct 26.

4

Retrospective Dosimetry for Yttrium-90 Radioembolization with Resin Microspheres.

J Vasc Interv Radiol. 2024 May;35(5):709-711. doi: 10.1016/j.jvir.2024.01.013.

5

Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma >7 cm.

J Vasc Interv Radiol. 2025 Mar 13. doi: 10.1016/j.jvir.2025.03.006.

6

Predictive Dosimetry and Outcomes of Hepatocellular Carcinoma Treated by Yttrium-90 Resin Microsphere Radioembolization: A Retrospective Analysis Using Technetium-99m Macroaggregated Albumin SPECT/CT and Planning Software.

J Vasc Interv Radiol. 2024 May;35(5):689-698.e3. doi: 10.1016/j.jvir.2023.11.026. Epub 2024 Jan 19.

7

Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.

J Vasc Interv Radiol. 2014 Oct;25(10):1595-603. doi: 10.1016/j.jvir.2014.06.028. Epub 2014 Aug 23.

8

The Utility of Unilobar Technetium-99m Macroaggregated Albumin to Predict Pulmonary Toxicity In Bilobar Hepatocellular Carcinoma prior to Yttrium-90 Radioembolization.

J Vasc Interv Radiol. 2016 Sep;27(9):1453-1456. doi: 10.1016/j.jvir.2016.06.004.

9

Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.

Trials. 2012 Aug 23;13:144. doi: 10.1186/1745-6215-13-144.

10

Resin-Based Yttrium-90 Radioembolization as a Bridging or Downstaging Treatment to Liver Transplantation for Hepatocellular Carcinoma.

J Vasc Interv Radiol. 2025 Feb;36(2):282-292. doi: 10.1016/j.jvir.2024.10.021. Epub 2024 Oct 26.

引用本文的文献

1

Are survival outcomes dependent on the tumour dose threshold of 139 Gy in patients with chemorefractory metastatic colorectal cancer treated with yttrium-90 radioembolization using glass particles? A real-world single-centre study.

Br J Radiol. 2024 Jun 18;97(1159):1255-1260. doi: 10.1093/bjr/tqae096.